GO
Loading...

Enter multiple symbols separated by commas

Medicine

More

  • CHICAGO, May 6- Poultry veterinarians in Minnesota believe an outbreak of avian flu has spread between farms, indicating the implementation of a U.S. strategy to contain the deadly bird disease failed in at least some cases. However, veterinarians now think the disease was transmitted between farms, Bill Hartmann, executive director of the Minnesota Board of...

  • *Alexion offers $225.92 per Synageva share in cash and stock. May 6- Alexion Pharmaceuticals Inc on Wednesday said it agreed to buy Synageva BioPharma Corp for $8.4 billion, more than twice its market value, to expand its offering of potentially high-priced medicines for rare diseases. The medicine, which can cost more than $500,000 per year, generated sales of...

  • *Alexion offers $225.92 per Synageva share in cash and stock. May 6- Drugmaker Alexion Pharmaceuticals Inc agreed to buy Synageva BioPharma Corp for $8.4 billion at a hefty premium to expand in the lucrative market for drugs that treat rare diseases. The drug, whose marketing application is being reviewed in the United States and Europe, treats a rare and...

  • It also scaled back plans to return 4 billion pounds of cash flowing from a $20 billion- plus asset swap with Novartis to investors, opting instead to pay a 1 billion special dividend. Chief Executive Andrew Witty is under pressure to demonstrate that the Novartis deal can revive GSK's fortunes by focusing it on consumer health and vaccines, following a slide in...

  • Two pharma giants merge in $8.4B deal Wednesday, 6 May 2015 | 8:01 AM ET
    Pharmaceuticals

    Alexion said it would buy Synageva for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease.

  • Alexion Pharma to buy Synageva BioPharma for $8.4 bln Wednesday, 6 May 2015 | 6:54 AM ET

    May 6- Drugmaker Alexion Pharmaceuticals Inc said it would buy Synageva BioPharma Corp for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease. Alexion's cash-and-stock offer values Synageva at $225.92 per share, representing a premium of 135.7 percent to the stock's close on Tuesday. The deal is expected to...

  • *More than 24 mln birds affected by flu virus- USDA. CHICAGO, May 5- The U.S. government approved the use of an additional $330 million in emergency funds to help contain the worst avian influenza outbreak in U.S. history, as infected bird cases soared and hundreds of Minnesota poultry workers learned they would lose their jobs. Agriculture Secretary Tom Vilsack's...

  • FRANKFURT, May 5- German genetic tests maker Qiagen NV reported a 4 percent fall in adjusted quarterly net profit as U.S. sales of its human papillomavirus test declined and the dollar strengthened, eroding the value of revenues in Europe. Qiagen said on Tuesday that U.S. sales of its HPV test, previously one of its main profit drivers, fell 54 percent due to lower...

  • IBM's Watson to guide cancer therapies at 14 centers Tuesday, 5 May 2015 | 2:00 PM ET

    NEW YORK, May 5- Fourteen U.S. and Canadian cancer institutes will use International Business Machines Corp's Watson computer system to choose therapies based on a tumor's genetic fingerprints, the company said on Tuesday, the latest step toward bringing personalized cancer treatments to more patients. Faced with such a data deluge, "the solution is going to be...

  • May 4- Corbus Pharmaceuticals Holdings Inc's experimental drug for cystic fibrosis, a rare lung-scarring disease, could be a real money spinner and pose a challenge to rival Vertex Pharmaceuticals Inc's successful treatment, Kalydeco. Corbus, a tiny biopharmaceutical company, received $5 million from the Cystic Fibrosis Foundation last month to develop...

  • U.S. top court rejects hepatitis B drug patent case Monday, 4 May 2015 | 9:40 AM ET

    WASHINGTON, May 4- The U.S. Supreme Court on Monday brought to an end Bristol-Myers Squibb Co's attempt to revive patent protection for its Baraclude treatment for hepatitis B. The high court declined to hear Bristol-Myers' challenge to an appeals court ruling in favor of generic rival Teva Pharmaceutical Industries Ltd, which had successfully challenged the...

  • CHICAGO, May 1- Iowa Governor Terry Branstad declared a state of emergency on Friday due to a rapidly expanding avian flu outbreak, soon after state agriculture officials announced four new poultry farms had initially tested positive for the virus. Iowa, the top egg-producing state in the United States, is the third state to declare a state of emergency because...

  • CHICAGO, May 1- Hog farmers are six times more likely than the general population to carry an infectious bacteria that can cause skin and respiratory problems and resists treatment from multiple drugs, according to a new U.S. research study. The study, published this week in the online journal Clinical Infectious Diseases, is the largest-ever examination of...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. The egg farm's owner, Rembrandt Foods, one of the top U.S. egg producers, confirmed the outbreak but disputed the number of birds affected.

  • April 30- The U.S. Food and Drug Administration on Thursday approved The Medicines Co's dry powder blood-clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The approval comes at a time Medicines Co is facing a drop in sales of its lead product, Angiomax anticoagulant injection, which accounted for over 80...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. Avian flu was "probable" at four other commercial farms in Buena Vista, Sioux and Clay counties, the Iowa Department of Agriculture and Land...

  • FDA approves Medicines Co's blood clotting agent Thursday, 30 Apr 2015 | 5:47 PM ET

    April 30- The U. S Food and Drug Administration approved the Medicines Co's dry powder blood clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The treatment, Raplixa, is a combination of two human plasma-derived blood-clotting proteins, fibrinogen and thrombin. Raplixa is used to control bleeding during...

  • LOS ANGELES, April 30- Gilead Sciences Inc said on Thursday its quarterly net profit nearly doubled, driven by sales of its novel hepatitis C drugs, as it topped Wall Street estimates. Excluding one-time items, Gilead earned $2.94 per share in the first quarter, outpacing the average Wall Street estimate of $2.32, according to Thomson Reuters I/B/E/S.

  • CHICAGO, April 30- An Iowa-based chicken broiler breeding farm has initially tested positive for the highly pathogenic H5 bird flu, the Iowa Department of Agriculture and Land Stewardship confirmed on Thursday. The facility in Kossuth County, Iowa, houses an estimated 19,000 birds, state officials said. The H5N2 strain has been reported in Arkansas, Idaho, Iowa,...

  • Pharma: No standout performers   Thursday, 30 Apr 2015 | 11:50 AM ET
    Pharma: No standout performers

    The earnings season for pharmaceutical has gone well so far, with the markets being happy with European pharma results, says Suki Virji, news editor at Scrip Intelligence.